Sonographic Evaluation of Gallbladder Distension Based on Interval Fasting Hours: A Prospective Study

ORIGINAL ARTICLE
Mohammed Alsaadi

 
For citation: Alsaadi M. Sonographic Evaluation of Gallbladder Distension Based on Interval Fasting Hours. International Journal of Biomedicine. 2025;15(3):535-539. doi:10.21103/Article15(3)_OA13
 
Originally published September 5, 2025

Abstract: 

The primary objective of this study was to systematically investigate the relationship between gallbladder (GB) distension and fasting duration (FD) by measuring the length and width of the gallbladder.
Methods and Results: A total of 30 healthy adult male volunteers (mean age: 23 ± 0.20 years; mean BMI: 23.16 ± 1.89 kg/m²) were recruited through convenience sampling. Participants were stratified into three groups based on their FD: Group A (n=10) with FD of 8 hours, Group B (n=10) with FD of 6 hours, and Group C (n=10) with FD of 4 hours. Each participant underwent a standardized GB ultrasound scan, during which the size and characteristics of the GB were measured in both transverse and longitudinal planes.
Longitudinal GB size increased significantly with FD (P=0.016): 46.84±8.83 mm (4 hours), 54.82±11.93 mm (6 hours), and 59.63±6.37 mm (8 hours). The transverse size showed no significant difference (P=0.193): 19.42±4.60 mm (4 hours), 3.48±5.35 mm (6 hours), and 22.56±5.27 mm (8 hours). GB wall thickness did not differ significantly across the three time points (P=0.766): 0.14±0.97 mm (4 hours), 0.22±0.57 mm (6 hours), and 0.42±1.03 mm (8 hours).  The GB neck was visualized in 40% of cases at 4 hours and 100% at 6 and 8 hours. Cystic duct visualization showed no significant difference (P=0.585), with rates of 40%, 60%, and 60% at 4, 6, and 8 hours, respectively.
Conclusion: Fasting for four hours can provide adequate GB visualization in most healthy individuals, with no significant issues evaluating the wall, cystic duct, or lumen. Prolonged fasting durations may improve the visualization of the GB neck, although they are not always necessary. Standardizing the fasting duration to four hours may optimize workflow while preserving diagnostic quality in routine practice.

Keywords: 
gallbladder distension • fasting duration • ultrasound visualization
References: 
  1. Afonso PD, Eiroa C, Rodríguez M, Martínez L. Ultrasound assessment of gallbladder and biliary tract disorders: diagnostic approach and common pathologies. Radiología. 2020;62(5):406–415.
  2. Bai Y, Zhang Y, Zhang H, Zhao Y. Influence of fasting duration on gallbladder volume and contraction index: a sonographic study. Journal of Ultrasound in Medicine.2019;38(8):2171–2176.
  3. Yoon WJ, Lee YJ, Kim KW, Lee SS. Sonographic evaluation of the gallbladder: usefulness of adequate fasting in real-time imaging. Ultrasonography. 2015;34(3):211–217.
  4. Lee DH, Kim SJ, Park JH, Choi H. Evaluation of gallbladder fasting times and its correlation with sonographic findings in healthy volunteers. BMC Medical Imaging. 2021;21(1):74.
  5. Zhu J, Luo X, Wang X, He S. Cholecystokinin-mediated gallbladder contraction in fasting: implications for ultrasonographic visualization. Clinical Imaging. 2017;43:145–150.
  6. Iqbal A, Khan S, Siddiqui T. Impact of inadequate fasting on ultrasound diagnosis of gallbladder diseases. Pakistan Journal of Radiology. 2018;28(2):71–74.
  7. ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA, on behalf of the American Diabetes Association. 7. Diabetes Technology: Standards of Care in Diabetes-2023. Diabetes Care. 2023 Jan 1;46(Suppl 1):S111-S127. doi: 10.2337/dc23-S007. PMID: 36507635; PMCID: PMC9810474.
  8. Krentz AJ, Bailey CJ. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs. 2005;65(3):385-411. doi: 10.2165/00003495-200565030-00005. PMID: 15669880.
  9. Khanna R, Kumar M, Khanna S, Shukla HS. Effect of pre-procedural fasting time on gallbladder sonographic visibility: a prospective study. Annals of Gastroenterology. 2014;27(4):345–349.
  10. van Breda Vriesman AC, Engelbrecht MR, Smithuis RH, Puylaert JB. Diffuse gallbladder wall thickening: differential diagnosis. AJR Am J Roentgenol. 2007 Feb;188(2):495-501. doi: 10.2214/AJR.05.1712. PMID: 17242260.
  11. Bortoff GA, Chen MY, Ott DJ, Wolfman NT, Routh WD. Gallbladder stones: imaging and intervention. Radiographics. 2000 May-Jun;20(3):751-66. doi: 10.1148/radiographics.20.3.g00ma16751. PMID: 10835126.
  12. Hashimoto M, Ishikawa T, Nishimura T, Takayama T. Advances in the imaging diagnosis of gallbladder diseases. World Journal of Gastroenterology. 2021;27(7):531–546.
  13. Sinan T, Leven H, Sheikh M. Is fasting a necessary preparation for abdominal ultrasound? BMC Med Imaging. 2003 Jul 22;3(1):1. doi: 10.1186/1471-2342-3-1. PMID: 12873354; PMCID: PMC183866.
  14. BURTON P, HARPER AA, HOWAT HT, SCOTT JE, VARLEY H. The use of cholecystokinin to test gall bladder function in man. Gut. 1960 Sep;1(3):193-204. doi: 10.1136/gut.1.3.193. PMID: 13689291; PMCID: PMC1413182.
  15. Jones MC, Vaqar S. Cholecystokinin Test. 2023 Jan 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 32809658.
  16. Sondh RS, Mankotia R. Reducing prolonged fasting for abdominal ultrasound scans. BMJ Open Qual. 2023 Aug;12(3):e002396. doi: 10.1136/bmjoq-2023-002396. PMID: 37541691; PMCID: PMC10407382.
  17. Chang JE, Kim H, Won D, Lee JM, Jung JY, Min SW, Hwang JY. Ultrasound assessment of gastric content in fasted patients before elective laparoscopic cholecystectomy: a prospective observational single-cohort study. Can J Anaesth. 2020 Jul;67(7):810-816. English. doi: 10.1007/s12630-020-01668-7. Epub 2020 Apr 20. PMID: 32314262.
  18. Ehrenstein BP, Froh S, Schlottmann K, Schölmerich J, Schacherer D. To eat or not to eat? Effect of fasting prior to abdominal sonography examinations on the quality of imaging under routine conditions: A randomized, examiner-blinded trial. Scand J Gastroenterol. 2009;44(9):1048-54. doi: 10.1080/00365520903075188. PMID: 19562622.

Download Article
Received July 7, 2025.
Accepted August 5, 2025.
©2025 International Medical Research and Development Corporation.